199 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
19 Apr 24
Current report (foreign)
6:12am
(SC CD Trial), a Phase 3, randomized, double-blind, placebo-controlled trial, which assessed the safety and efficacy of an SC formulation of ENTYVIO … ) at Week 52.1 In clinical studies, the ENTYVIO SC safety profile was generally consistent with the known safety profile of ENTYVIO IV, with the addition
6-K
TAK
Takeda Pharmaceutical Co
15 Apr 24
Current report (foreign)
6:02am
the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its
6-K
TAK
Takeda Pharmaceutical Co
9 Feb 24
Current report (foreign)
6:03am
exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
of ENTYVIO, the clinical safety and efficacy data, and conclusions from the pivotal VISIBLE 1 trial supporting the ENTYVIO SC BLA. VISIBLE 1 assessed … the safety and efficacy of a SC formulation of ENTYVIO as maintenance therapy in 216 adult patients with moderately to severely active UC who achieved clinical
6-K
TAK
Takeda Pharmaceutical Co
1 Feb 24
Current report (foreign)
6:18am
rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel
6-K
EX-99.1
02yx5j4eh5524xkw92id
1 Feb 24
Current report (foreign)
6:06am
6-K
1tkmw mpmhzpf7
16 Jan 24
Current report (foreign)
6:01am
6-K
EX-99.1
jrw5nmage5mn hbudg
14 Dec 23
Current report (foreign)
6:01am
6-K
EX-99.1
ru9c szlo0bb9
30 Nov 23
Current report (foreign)
6:01am
6-K
ml23l 61ga
13 Nov 23
Current report (foreign)
6:05am
6-K
EX-99.1
pwss15w ioo72
30 Oct 23
Current report (foreign)
6:02am
6-K
mb92hm2
30 Oct 23
Current report (foreign)
6:02am
6-K
6ulb4bby ol
26 Oct 23
Current report (foreign)
6:22am
6-K
EX-99.1
yaawazj8yp hrhir2a
26 Oct 23
Current report (foreign)
6:20am
6-K
EX-99.1
rlb22u2
18 Oct 23
Current report (foreign)
6:21am
6-K
EX-99.1
72qatf3q9 r3s
18 Oct 23
Current report (foreign)
6:20am
6-K
le4tf5b2
2 Oct 23
Current report (foreign)
6:17am
6-K
6bp4fidu5o679
28 Sep 23
Current report (foreign)
6:17am
6-K
gs80zxgd
11 Sep 23
Current report (foreign)
6:50am
6-K
4jn82u5b 9ar
1 Aug 23
Current report (foreign)
6:10am